Pfizer Italia S.r.l.
UkraineAll drugs from this manufacturer
-
The drug is used for adjuvant therapy in postmenopausal women with early-stage invasive breast cancer (after 2–3 years of tamoxifen therapy), as well as for the treatment of advanced breast cancer in postmenopausal women if the disease progresses after the use of antiestrogens.
Dosage form: tablets, sugar-coated
Active substance Dosage exemestane 25 mg ATC: L02BG06
-
The drug is used to suppress lactation (breastfeeding) after childbirth or abortion, as well as to treat conditions associated with elevated prolactin levels (e.g., menstrual cycle disorders, infertility, or pituitary tumors).
Dosage form: tablets
Active substance Dosage cabergoline 0.5 mg ATC: G02CB03
-
The drug is used to treat a wide range of diseases: endocrine disorders (e.g., adrenal insufficiency), rheumatic diseases (arthritis, psoriatic arthritis), skin problems (severe psoriasis, dermatitis), allergic conditions (asthma, rhinitis), diseases of the eyes, respiratory organs, blood, and other inflammatory processes.
Dosage form: tablets
Active substance Dosage methylprednisolone 4 mg ATC: H02AB04
-
The drug is used to treat a wide range of diseases: endocrine disorders (e.g., adrenal insufficiency), rheumatic diseases (arthritis, gout), skin problems (psoriasis, dermatitis), allergic conditions (asthma, rhinitis), eye diseases, respiratory diseases, blood diseases, and other inflammatory processes.
Dosage form: tablets
Active substance Dosage methylprednisolone 16 mg ATC: H02AB04
-
The drug is used to treat a wide range of diseases, including endocrine disorders (adrenal insufficiency), rheumatic diseases (arthritis, gout), skin diseases (psoriasis, dermatitis), severe allergic conditions (asthma, rhinitis), diseases of the eyes, respiratory organs, blood, and certain oncological diseases.
Dosage form: tablets
Active substance Dosage methylprednisolone 32 mg ATC: H02AB04
-
The drug is indicated for the treatment of post-stroke conditions, vascular dementia (multi-infarct dementia), as well as degenerative conditions associated with dementia (e.g., Alzheimer's or Parkinson's disease).
Dosage form: tablets, film-coated
Active substance Dosage nicergoline 30 mg ATC: C04AE02
-
The drug is prescribed for acute and chronic cerebral circulation disorders (due to atherosclerosis, thrombosis, or embolism), transient ischemic attacks, headaches, and as adjunctive treatment for systemic arterial hypertension.
Dosage form: tablets, sugar-coated
Active substance Dosage nicergoline 5 mg ATC: C04AE02
-
The drug is indicated for acute and chronic cerebral circulation disorders (due to atherosclerosis, thrombosis, or embolism), transient ischemic attacks, headaches, and as adjunctive treatment for systemic arterial hypertension.
Dosage form: tablets, sugar-coated
Active substance Dosage nicergoline 10 mg ATC: C04AE02
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC after surgery, as well as progressive neuroendocrine tumors of the pancreas.
Dosage form: capsules
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
-
The drug is used for the treatment of gastrointestinal stromal tumor (after disease progression or intolerance to other treatment), progressive renal cell carcinoma, adjuvant therapy for renal cell carcinoma after surgery, as well as for the treatment of progressive neuroendocrine tumors of the pancreas.
Dosage form: capsules
Active substance Dosage sunitinib 25 mg ATC: L01EX01
-
The drug is prescribed for the treatment of gastrointestinal stromal tumor (GIST), progressive renal cell carcinoma (RCC), adjuvant therapy for RCC (for adults at high risk of recurrence after nephrectomy), as well as progressive neuroendocrine tumors of the pancreas.
Dosage form: capsules
Active substance Dosage sunitinib 50 mg ATC: L01EX01
-
The drug is used for the treatment of gastrointestinal stromal tumor (after disease progression or intolerance to other treatment), progressive renal cell carcinoma, adjuvant therapy of renal cell carcinoma after surgery, as well as for the treatment of progressive neuroendocrine tumors of the pancreas.
Dosage form: capsules
Active substance Dosage sunitinib 37.5 mg ATC: L01EX01